搜索筛选:
搜索耗时0.0287秒,为你在为你在61,042,058篇论文里面共找到 1 篇相符的论文内容
发布年度:
Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients wit
[期刊论文] 作者：Huiping Li,Rongrui Liu,Bin Shao,Ran Ran,Guohong Song,Ke Wang,Yehui Shi,Jihong Liu,Wenjing Hu,Fu Chen,,
来源：中国癌症研究（英文版） 年份：2020
Objective: Fluzoparib (SHR3162) is a novel,potent poly(ADP-ribose) polymerases (PARP)1,2 inhibitor that showed anti-tumor activity in xenograft models.We conduc...
相关搜索：
